Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)

Clinical trial NCT02971007 · COMPLETED

Trial details

NCT number: NCT02971007
Sponsor: Matinas BioPharma Nanotechnologies, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Vulvovaginitis Yeast Infection Yeast Infection Vaginal Candidiasis, Vulvovaginal

Start date: 2016-11-01
Primary completion: 2017-05-01
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.